NCT06155942View on ClinicalTrials.gov

Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes

NANot yet recruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

January 15, 2026

Study Completion Date

January 15, 2028

Conditions
Parkinson DiseaseProgressive Supranuclear Palsy
Interventions
PROCEDURE

7 Tesla MRI

Patients will have a 7T MRI and questionnaires

Trial Locations (6)

13080

Ch Pays D'Aix, Aix-en-Provence

13400

Hôpital Privé La Casamance - Service de Neurologie, Aubagne

30000

CENTRE HOSPITALIER NIMES - Service de Neurologie, Nîmes

83000

CENTRE HOSPITALIER SAINTE MUSSE - Toulon, Toulon

84000

Centre Hospitalier Avignon - Service de Neurologie, Avignon

06000

CENTRE HOSPITALIER UNIVERSITAIRE NICE - Service de Neurologie, Nice

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT06155942 - Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes | Biotech Hunter | Biotech Hunter